Literature DB >> 8192558

Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study.

J H Eckfeldt1, L E Chambless, Y L Shen.   

Abstract

We report the within-person, between-person, and methodological variances of a number of chemical analytes for free-living, middle-aged adults who participated in the Atherosclerosis Risk in Communities Study's Intraindividual Variability Study. The Atherosclerosis Risk in Communities Study is a National Institutes of Health-sponsored multicenter study of atherosclerotic risk factors. In the Atherosclerosis Risk in Communities Study and its Intraindividual Variability Study, concentrations of the following 12 chemical analytes were measured in serum from fasting individuals: sodium, calcium, potassium, creatinine, albumin, total protein, magnesium, phosphorus, urea, insulin, glucose, and urate. The analytes are listed in order of the increasing reliability coefficient (ie, the fraction that between-person variance represents of the total observed population variance), which ranged from .59 for sodium to .91 for urate. The reliability coefficient is a strong predictor of the possibility of finding statistical correlations between measured analyte concentrations and disease occurrence in an epidemiological study like the Atherosclerosis Risk in Communities Study. The within-person variance and methodological variance are also useful in computing confidence intervals for sequential laboratory test results in patients and evaluating limits for internal quality control and proficiency testing programs.

Entities:  

Mesh:

Year:  1994        PMID: 8192558

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  55 in total

1.  Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study).

Authors:  Laura J Rasmussen-Torvik; Hiroshi Yatsuya; Elizabeth Selvin; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2010-05-15       Impact factor: 2.778

2.  Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ayokanmi Adeniyi; Aaron R Folsom; Frederick L Brancati; Moise Desvorieux; James S Pankow; Herman Taylor
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

3.  Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples.

Authors:  Oemer-Necmi Goek; Anna Köttgen; Ron C Hoogeveen; Christie M Ballantyne; Josef Coresh; Brad C Astor
Journal:  Nephrol Dial Transplant       Date:  2012-01-28       Impact factor: 5.992

4.  Reference change values of blood analytes from physically active subjects.

Authors:  Lázaro Alessandro S Nunes; René Brenzikofer; Denise Vaz de Macedo
Journal:  Eur J Appl Physiol       Date:  2010-05-06       Impact factor: 3.078

5.  Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ranee Chatterjee; Hsin-Chieh Yeh; Tariq Shafi; Elizabeth Selvin; Cheryl Anderson; James S Pankow; Edgar Miller; Frederick Brancati
Journal:  Arch Intern Med       Date:  2010-10-25

6.  Defining incident chronic kidney disease in the research setting: The ARIC Study.

Authors:  Lori D Bash; Josef Coresh; Anna Köttgen; Rulan S Parekh; Tibor Fulop; Yaping Wang; Brad C Astor
Journal:  Am J Epidemiol       Date:  2009-06-17       Impact factor: 4.897

7.  Biological Variability of Estimated GFR and Albuminuria in CKD.

Authors:  Sushrut S Waikar; Casey M Rebholz; Zihe Zheng; Shelley Hurwitz; Chi-Yuan Hsu; Harold I Feldman; Dawei Xie; Kathleen D Liu; Theodore E Mifflin; John H Eckfeldt; Paul L Kimmel; Ramachandran S Vasan; Joseph V Bonventre; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2018-07-18       Impact factor: 8.860

8.  Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Authors:  Casey M Rebholz; Elizabeth Selvin; Menglu Liang; Christie M Ballantyne; Ron C Hoogeveen; David Aguilar; John W McEvoy; Morgan E Grams; Josef Coresh
Journal:  Kidney Int       Date:  2017-08-31       Impact factor: 10.612

9.  Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Honglei Chen; Thomas H Mosley; Alvaro Alonso; Xuemei Huang
Journal:  Am J Epidemiol       Date:  2009-03-18       Impact factor: 4.897

10.  Iterative Outlier Removal: A Method for Identifying Outliers in Laboratory Recalibration Studies.

Authors:  Christina M Parrinello; Morgan E Grams; Yingying Sang; David Couper; Lisa M Wruck; Danni Li; John H Eckfeldt; Elizabeth Selvin; Josef Coresh
Journal:  Clin Chem       Date:  2016-05-19       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.